Archives

Establishing a genetic diagnosis for patients with unexplained infantile or childhood-onset epilepsy can help individualize treatment

Delays tied to more seizures prior to diagnosis, conversion to motor-type seizures, potentially preventable injuries

Event-free survival prolonged with axi-cel versus standard care as second-line therapy for refractory, relapsed disease

Screening protocol could identify candidates for neuromodulation therapies who could skip a formal in-person psychological assessment

Machine learning used to generate risk score based on clinical data and measurements from stress cardiovascular magnetic resonance

Measurements of cardiac performance with transthoracic echocardiography may reveal subclinical cardiac dysfunction

Two-year overall survival 72 percent for those starting with N/I, 52 percent for those starting with dabrafenib/trametinib

In post-COVID-19 peak period in 2020, CT volume still down for cancer screening and initial workup with inconsistent recovery for active cancer

Higher ACR category on dynamic contrast-enhanced breast MRI seen in 23 of 48 women with versus without intrauterine device in place

Cre8 EVO stents noninferior to Resolute Onyx stents for target-lesion failure composite outcome at one year